![Roy S. Walzer](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Aktive Positionen von Roy S. Walzer
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Cell Analysis Ltd.
![]() Cell Analysis Ltd. BiotechnologyHealth Technology Cell Analysis Ltd. develops applications and solutions based on cell analysis. It offers food authenticity, agricultural breed genetics, and diagnostic products for human genetic disorders. The company was founded in 1999 and is headquartered in Slough, the United Kingdom. | Direktor/Vorstandsmitglied | 29.04.2018 | - |
Litchfield Equities Ltd. | Präsident | - | - |
Treasurer | - | - |
Karriereverlauf von Roy S. Walzer
Ehemalige bekannte Positionen von Roy S. Walzer
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Advanced Viral Research Corp.
![]() Advanced Viral Research Corp. Pharmaceuticals: MajorHealth Technology Advanced Viral Research Corp. is a biopharmaceutical company, engages in the research, development, and commercialization of small molecule therapeutics that address medical needs for various degenerative conditions. Its products include AVR118, a cytoprotective drug composed of a complex mixture of protein and ribonucleic acid components; AVR123, a form of AVR118 specially designed for dermatology applications, which is in Phase II clinical trials; AVR147, an inhibitor of a cancer target known as a proteasome; AVR168 that is a natural product, which inhibits a member of a family of motor proteins that are responsible for the assembly and function of microtubules during cell division. The company was founded in July 1985 and is headquartered in Yonkers, NY. | Direktor/Vorstandsmitglied | 01.06.2002 | 23.03.2009 |
Statistik
International
Vereinigte Staaten | 3 |
Vereinigtes Königreich | 2 |
Operativ
Director/Board Member | 2 |
President | 1 |
Treasurer | 1 |
Sektoral
Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 3 |
---|---|
Advanced Viral Research Corp.
![]() Advanced Viral Research Corp. Pharmaceuticals: MajorHealth Technology Advanced Viral Research Corp. is a biopharmaceutical company, engages in the research, development, and commercialization of small molecule therapeutics that address medical needs for various degenerative conditions. Its products include AVR118, a cytoprotective drug composed of a complex mixture of protein and ribonucleic acid components; AVR123, a form of AVR118 specially designed for dermatology applications, which is in Phase II clinical trials; AVR147, an inhibitor of a cancer target known as a proteasome; AVR168 that is a natural product, which inhibits a member of a family of motor proteins that are responsible for the assembly and function of microtubules during cell division. The company was founded in July 1985 and is headquartered in Yonkers, NY. | Health Technology |
Cell Analysis Ltd.
![]() Cell Analysis Ltd. BiotechnologyHealth Technology Cell Analysis Ltd. develops applications and solutions based on cell analysis. It offers food authenticity, agricultural breed genetics, and diagnostic products for human genetic disorders. The company was founded in 1999 and is headquartered in Slough, the United Kingdom. | Health Technology |
Litchfield Equities Ltd. |
- Börse
- Insiders
- Roy S. Walzer
- Erfahrung